Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2010
11/11/2010WO2010128672A1 Neovascularization inducer comprising genetically recombined gelatin
11/11/2010WO2010127640A1 High penetration prodrug compositions of peptides and peptide-related compounds
11/11/2010WO2010127396A1 One or more of vigna marina, cocos nucifera l. or terminalia catappa l. extracts for treating wounds, skin disorders and hair loss
11/11/2010WO2010105636A8 Topical compositions comprising interleukin-1 alpha and peptides and cosmetic methods thereof
11/11/2010WO2010091894A3 Methods of treating hair related conditions
11/11/2010WO2010079978A3 Composition for improving inflammatory disease using abh antigens
11/11/2010WO2010042886A3 Pyrones for the treatment of metabolic disorders
11/11/2010WO2009135581A9 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/11/2010US20100287637 Methods of blocking tissue destruction by autoreactive t cells
11/11/2010US20100286285 Pharmaceutical composition comprising oleaginous ointments and vitamin D or its derivatives in the solubilized state
11/11/2010US20100286279 Methods of Synthesis of Certain Hydroxamic Acid Compounds
11/11/2010US20100286278 Composition comprising an HDAC inhibitor in combination with a retinoid
11/11/2010US20100286275 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
11/11/2010US20100286272 Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications
11/11/2010US20100286271 Nitro-alkyl Compound Compositions
11/11/2010US20100286247 Methods of Protection from Oxidative Stress
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286216 Composition having a high osmotic activity and exhibiting antimicrobial, anti-inflammatory, and regenerative effects
11/11/2010US20100286205 Wound care formulation
11/11/2010US20100286191 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators
11/11/2010US20100286190 Certain substituted ureas, as modulators of kinase activity
11/11/2010US20100286141 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways
11/11/2010US20100286128 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine-receptor ligands
11/11/2010US20100286119 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
11/11/2010US20100286105 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative
11/11/2010US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses
11/11/2010US20100286102 Formulations comprising ceramides and/or pseudoceramides and (alpha-)bisabolol for combating skin damage
11/11/2010US20100286101 Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability
11/11/2010US20100286071 Finger-1 Peptide Analogs of the TGF-Beta Superfamily
11/11/2010US20100286065 Topical methods and compositions for the treatment of eye diseases and conditions
11/11/2010US20100286060 Specific binding agents of human angiopoeitin-2
11/11/2010US20100286056 Compositions for reducing oxidative stress and uses thereof
11/11/2010US20100286055 Use of wnt3a for acceleration of wound healing
11/11/2010US20100286042 Medicinal Composition Containing Highly Functionalized Chimeric Protein
11/11/2010US20100286040 Pro-angiogenic peptides and uses thereof
11/11/2010US20100286037 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase
11/11/2010US20100285155 Cleanser composition and methods for using the same
11/11/2010US20100285154 Use of lignan compounds for treating or preventing inflammatory disease
11/11/2010US20100285129 Novel agent for salting out active principles in dressings containing at least one of fatty substance
11/11/2010US20100285110 Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser
11/11/2010US20100285102 Colloidal collagen burn wound dressing produced from jellyfish
11/11/2010US20100285101 Composite nonwoven fibrous webs and methods of making and using the same
11/11/2010US20100285094 Polymeric compositions and methods of making and using thereof
11/11/2010US20100285077 Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid
11/11/2010US20100285073 a micro-rna family that modulates fibrosis and uses thereof
11/11/2010US20100285035 High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1
11/11/2010US20100285034 Method
11/11/2010US20100285031 Hox Compositions and Methods
11/11/2010US20100285019 Anti-IL-17F Antibodies and Methods of Use Thereof
11/11/2010US20100284995 Temperature sensitive mutants of matrix metalloproteases and uses thereof
11/11/2010US20100284979 Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria
11/11/2010US20100284970 Benzimidazole modulators of h1 receptor and/or ns4b protein
11/11/2010US20100284938 Penetrating pharmaceutical foam
11/11/2010US20100284913 Methods and compositions for studying, imaging, and treating pain
11/11/2010DE102009018133A1 Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen A pharmaceutical composition for the treatment of dermatological autoimmune diseases
11/11/2010CA2761489A1 High penetration prodrug compositions of peptides and peptide-related compounds
11/11/2010CA2760812A1 One or more of vigna marina, cocos nucifera l. or terminalia catappa l. extracts for treating wounds, skin disorders and hair loss
11/11/2010CA2760575A1 Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
11/11/2010CA2760450A1 Topical compositions comprising an alkoxylated diphenylacrylate compound and an aryl carboxylic ester
11/10/2010EP2248828A1 Method for treating inflammation
11/10/2010EP2248526A1 Compositions containing an extract of asparagus and use thereof
11/10/2010EP2248522A1 Immunosuppressive macrolide powder for oral suspension
11/10/2010EP2247563A1 13,13-dimethyl-des-c,d analogs of 1alpha, 25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
11/10/2010EP2247294A2 Macrolides for treating diseases mediated through pde inhibition
11/10/2010EP1833840B9 Potent lna oligonucleotides for the inhibition of hif-1a
11/10/2010EP1460995B1 Transdermal transport of compounds
11/10/2010EP1454950B1 Pullulan-containing powder, process for producing the same and use thereof
11/10/2010EP1030867B1 Mammalian milk growth factor
11/10/2010EP0958362B1 Isolation and use of motoneuronotrophic factors
11/10/2010CN201624425U Coix seed health care pillowcase
11/10/2010CN1846738B Medicine composition and its preparation process and quality control method
11/10/2010CN1708283B Skin preparations for external use
11/10/2010CN1561208B Methods to mobilize progenitor/stem cells
11/10/2010CN101883765A Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
11/10/2010CN101883610A Cosmetic or dermatological composition for topical application
11/10/2010CN101883566A Mequitazine for treating or preventing pathologies involving histamine h4 receptors
11/10/2010CN101880286A Water-soluble amino-acid ester derivative of ginkgolide B
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101879309A Application of human urinary kallidinogenase in preparing medicine for treating diabetic foot ulcers
11/10/2010CN101879307A Preparation for repairing active cells
11/10/2010CN101879304A Functions of placenta polypeptide injection in treating bone injury and healing wound surfaces
11/10/2010CN101879300A Oral administration medicament for treating alopecia
11/10/2010CN101879295A Chinese medicinal psoriasis-eliminating decoction for treating blood stasis type psoriasis
11/10/2010CN101879292A Application of fructus amomi volatile oil in preparing medicament for treating fungal infectious psoriasis
11/10/2010CN101879283A Novel membrane spraying preparation for skin trauma and preparation method
11/10/2010CN101879281A Formula of honey refined gum for treating chloasma and preparation method thereof
11/10/2010CN101879267A Compound tincture for treating foot helosis
11/10/2010CN101879255A Medicinal preparation used for treating frostbite and having thrombolysis effect
11/10/2010CN101879254A Chinese medicinal ointment for treating neonate omphalitis
11/10/2010CN101879252A Pharmaceutical composition having function of removing chloasma and preparation method thereof
11/10/2010CN101879224A Oral administration medicament for treating psoriasis
11/10/2010CN101879222A Method for extracting Chinese medicinal composition
11/10/2010CN101879220A Medicament for treating leucoderma and preparation method thereof
11/10/2010CN101879192A Medicine composition with blood tonification and beautification effects
11/10/2010CN101879185A Liquid medicament for preventing and treating underarm odor
11/10/2010CN101879182A Composite polysaccharide for resisting radiation
11/10/2010CN101879176A Compound ivermectin injection for treating mite infection of dog and preparation method thereof
11/10/2010CN101475920B Preparation method of Bacillus pumilus for treating burn and metabolite
1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 1065